{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:26:29Z","timestamp":1791404789341,"version":"4.3.3"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Coll\u00e8ge des Maladies Infectieuses"},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA210806"],"award-info":[{"award-number":["R01CA210806"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["U01AA013566"],"award-info":[{"award-number":["U01AA013566"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Veterans Aging Cohort Study"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>We ascertained incidence of opportunistic infections (OIs) in people with human immunodeficiency virus (PWH) with cancer undergoing chemotherapy with non-human immunodeficiency virus (HIV) comparators.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We identified 2106 PWH and 2981 uninfected Veterans with cancer who received at least 1 dose of chemotherapy between 1996 and 2017 from the Veterans Aging Cohort Study. We ascertained incident OIs within 6 months of chemotherapy amongst zoster, cytomegalovirus, tuberculosis, Candida esophagitis, Pneumocystis jirovecii pneumonia (PCP), toxoplasmosis, Cryptococcosis, atypical Mycobacterium infection, Salmonella bacteremia, histoplasmosis, coccidioidomycosis, or progressive multifocal leukoencephalopathy. We used Poisson methods to calculate OI incidence rates by HIV status, stratifying for hematological and nonhematological tumors. We compared OI rates by HIV status, using inverse probability weights of HIV status, further adjusting for PCP prophylaxis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We confirmed 106 OIs in 101 persons. Adjusted OI incidence rate ratios (IRRs) indicated higher risk in PWH for all cancers (IRR, 4.8; 95% confidence interval [CI], 2.8\u20138.2), hematological cancers (IRR, 8.2; 95% CI, 2.4\u201327.3), and nonhematological cancers (IRR, 3.9; 95% CI, 2.1\u20137.2). Incidence rate ratios were not significantly higher in those with CD4 &amp;gt;200 cells\/mm3 and viral load &amp;lt;500 copies\/mL (IRR, 1.8; 95% CI, 0.9\u20133.2). All PCP cases (n\u2005=\u200511) occurred in PWH, with 2 microbiologically unconfirmed cases among 1467 PWH with nonhematological cancers, no PCP prophylaxis, and CD4 counts &amp;gt;200\/mm3.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Veterans with HIV undergoing chemotherapy had higher rates of OIs than uninfected Veterans, particularly those with hematological cancers, but not in PWH with HIV controlled disease. Our study does not support systematic PCP prophylaxis in solid tumors in PWH with HIV controlled disease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofab389","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T15:29:23Z","timestamp":1626708563000},"source":"Crossref","is-referenced-by-count":12,"title":["Risks of Opportunistic Infections in People With Human Immunodeficiency Virus With Cancers Treated With Chemotherapy"],"prefix":"10.1093","volume":"8","author":[{"given":"Alain","family":"Makinson","sequence":"first","affiliation":[{"name":"University Hospital Montpellier, Institut National de Science et de Recherche M\u00e9dicale U1175 and University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley S","family":"Park","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Stone","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mt Sinai, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Tate","sequence":"additional","affiliation":[{"name":"Veteran Affairs Connecticut Healthcare System, West Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C","family":"Rodriguez-Barradas","sequence":"additional","affiliation":[{"name":"Michael E. DeBakey VAMC and Baylor College of Medicine, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon T","family":"Brown","sequence":"additional","affiliation":[{"name":"James J. Peters VA Medical Center, Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne","family":"Wadia","sequence":"additional","affiliation":[{"name":"Veteran Affairs Connecticut Healthcare System, West Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Crothers","sequence":"additional","affiliation":[{"name":"VA Puget Sound Health Care System and University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Bedimo","sequence":"additional","affiliation":[{"name":"VA North Texas Health Care Center, Dallas, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew Bidwell","family":"Goetz","sequence":"additional","affiliation":[{"name":"VA Greater Los Angeles Health Care System, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Shebl","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Reynes","sequence":"additional","affiliation":[{"name":"University Hospital Montpellier, Institut National de Science et de Recherche M\u00e9dicale U1175 and University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Le","family":"Moing","sequence":"additional","affiliation":[{"name":"University Hospital Montpellier, Institut National de Science et de Recherche M\u00e9dicale U1175 and University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4051-4861","authenticated-orcid":false,"given":"Keith M","family":"Sigel","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mt Sinai, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,19]]},"reference":[{"key":"2021082709125397000_CIT0001","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/QAD.0b013e32834e8805","article-title":"Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy","volume":"26","author":"Kowalska","year":"2012","journal-title":"AIDS"},{"key":"2021082709125397000_CIT0002","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","article-title":"Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration","volume":"384","author":"Smith","year":"2014","journal-title":"Lancet"},{"key":"2021082709125397000_CIT0003","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S1473-3099(15)00056-0","article-title":"Future challenges for clinical care of an ageing population infected with HIV: a modelling study","volume":"15","author":"Smit","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"2021082709125397000_CIT0004","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1093\/cid\/cit497","article-title":"Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort","volume":"57","author":"Hleyhel","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2021082709125397000_CIT0005","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/QAD.0000000000000382","article-title":"Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort","volume":"28","author":"Hleyhel","year":"2014","journal-title":"AIDS"},{"key":"2021082709125397000_CIT0006","first-page":"468","article-title":"HIV infection, immunosuppression, and age at diagnosis of non-AIDS-defining cancers","volume":"64","author":"Shiels","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2021082709125397000_CIT0007","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/cid\/ciu869","article-title":"Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults","volume":"60","author":"Althoff","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2021082709125397000_CIT0008","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/QAD.0000000000000922","article-title":"Prevalence of non-HIV cancer risk factors in persons living with HIV\/AIDS: a meta-analysis","volume":"30","author":"Park","year":"2016","journal-title":"AIDS"},{"key":"2021082709125397000_CIT0009","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/QAD.0000000000001112","article-title":"Time trends in cancer incidence in persons living with HIV\/AIDS in the antiretroviral therapy era: 1997-2012","volume":"30","author":"Park","year":"2016","journal-title":"AIDS"},{"key":"2021082709125397000_CIT0010","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1200\/JCO.18.00374","article-title":"Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J Clin Oncol"},{"key":"2021082709125397000_CIT0011","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1200\/JCO.2012.45.8661","article-title":"Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline","volume":"31","author":"Flowers","year":"2013","journal-title":"J Clin Oncol"},{"key":"2021082709125397000_CIT0012","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1093\/jac\/dkw157","article-title":"ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Maertens","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2021082709125397000_CIT0013","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1016\/S2352-3018(15)00006-5","article-title":"CD4\/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study","volume":"2","author":"Mussini","year":"2015","journal-title":"Lancet HIV"},{"key":"2021082709125397000_CIT0014","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/jac\/dku362","article-title":"Immuno-virological and clinical impacts of treating cancer in patients living with HIV","volume":"70","author":"Le Moal","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2021082709125397000_CIT0015","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1080\/10428194.2017.1403597","article-title":"Combination antiretroviral therapy accelerates immune recovery in patients with HIV-related lymphoma treated with EPOCH: a comparison within one prospective trial AMC034","volume":"59","author":"Tan","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"2021082709125397000_CIT0016","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/QAI.0b013e318285d934","article-title":"Prolonged decrease of CD4+ T lymphocytes in HIV-1-infected patients after radiotherapy for a solid tumor","volume":"62","author":"Sankatsing","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2021082709125397000_CIT0017","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/01.mlr.0000118861.56848.ee","article-title":"Comparison of the Elixhauser and Charlson\/Deyo methods of comorbidity measurement in administrative data","volume":"42","author":"Southern","year":"2004","journal-title":"Med Care"},{"key":"2021082709125397000_CIT0018","first-page":"965","article-title":"Letermovir prophylaxis for cytomegalovirus","volume":"378","author":"Marty","year":"2018","journal-title":"N Engl J Med"},{"key":"2021082709125397000_CIT0019","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/OLQ.0b013e3181d73feb","article-title":"Inverse probability weighting in sexually transmitted infection\/human immunodeficiency virus prevention research: methods for evaluating social and community interventions","volume":"37","author":"Lippman","year":"2010","journal-title":"Sex Transm Dis"},{"key":"2021082709125397000_CIT0020","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1182\/blood-2007-10-115659","article-title":"Immunologic recovery in survivors following chemotherapy for AIDS-related non-Hodgkin lymphoma","volume":"111","author":"Bower","year":"2008","journal-title":"Blood"},{"key":"2021082709125397000_CIT0021","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood-2004-08-3300","article-title":"Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials","volume":"105","author":"Spina","year":"2005","journal-title":"Blood"},{"key":"2021082709125397000_CIT0022","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02066-2019","article-title":"First-line carboplatin plus pemetrexed with pemetrexed maintenance in HIV+ patients with advanced non-squamous non-small cell lung cancer: the phase II IFCT-1001 CHIVA trial","author":"Lavole","year":"2020","journal-title":"Eur Respir J"},{"key":"2021082709125397000_CIT0023","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/j.ejca.2011.06.036","article-title":"Colorectal cancer in HIV positive individuals: the immunological effects of treatment","volume":"47","author":"Alfa-Wali","year":"2011","journal-title":"Eur J Cancer"},{"key":"2021082709125397000_CIT0024","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/infdis\/jiw085","article-title":"Incidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV-infected persons in the United States and Canada, 2000-2010","volume":"214","author":"Buchacz","year":"2016","journal-title":"J Infect Dis"},{"key":"2021082709125397000_CIT0025","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/cid\/ciu1161","article-title":"Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort","volume":"60","author":"Grabar","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2021082709125397000_CIT0026","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1093\/cid\/ciz1090","article-title":"Herpes zoster risk in immunocompromised adults in the United States: a systematic review","volume":"71","author":"McKay","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021082709125397000_CIT0027","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S1473-3099(18)30600-5","article-title":"Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)","volume":"19","author":"Cordonnier","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2021082709125397000_CIT0028","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/infdis\/jit344","article-title":"Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults","volume":"208","author":"Mullane","year":"2013","journal-title":"J Infect Dis"},{"key":"2021082709125397000_CIT0029","doi-asserted-by":"crossref","first-page":"986","DOI":"10.6004\/jnccn.2018.0066","article-title":"Cancer in people living with HIV, version 1.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"Reid","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"2021082709125397000_CIT0030","first-page":"1","article-title":"British HIV Association guidelines for HIV-associated malignancies 2014","volume":"15 Suppl 2","author":"Bower","year":"2014","journal-title":"HIV Med"},{"key":"2021082709125397000_CIT0031","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2169\/internalmedicine.3907-19","article-title":"Pneumocystis jirovecii pneumonia in a patient with breast cancer receiving neoadjuvant dose-dense chemotherapy","volume":"59","author":"Watanabe","year":"2020","journal-title":"Intern Med"},{"key":"2021082709125397000_CIT0032","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.lungcan.2007.02.010","article-title":"Pneumocystis pneumonia in a patient with non-small cell lung cancer (NSCLC) treated with pemetrexed containing regimen","volume":"57","author":"Velcheti","year":"2007","journal-title":"Lung Cancer"},{"key":"2021082709125397000_CIT0033","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1089\/aid.2015.0114","article-title":"Loss of virologic control and severe pneumocystis pneumonia in an HIV-infected patient receiving chemotherapy for non-small cell lung cancer","volume":"32","author":"Doll","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2021082709125397000_CIT0034","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/QAD.0000000000001005","article-title":"CD4+\/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy","volume":"30","author":"Castilho","year":"2016","journal-title":"AIDS"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofab389\/39118342\/ofab389.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/8\/8\/ofab389\/40024285\/ofab389.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/8\/8\/ofab389\/40024285\/ofab389.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T09:14:58Z","timestamp":1630055698000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofab389\/6324075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,19]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofab389","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,8,1]]},"published":{"date-parts":[[2021,7,19]]},"article-number":"ofab389"}}